DNA-Biofunctionalization of CTAC-Capped Gold Nanocubes

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Rapid, sensitive detection is crucial for clinical diagnostics and disease control.
• Gold nanoparticles offer unique optical properties and signal transduction for enhanced analytical performance.
• Sharp-edged nanoparticles, like gold nanocubes, provide stronger electromagnetic field enhancements for biosensing.

Purpose of the Study:

• To develop a reliable protocol for biofunctionalizing gold nanocubes with DNA.
• To improve nanoparticle biocompatibility, specificity, and stability for analytical applications.
• To demonstrate a two-step ligand exchange protocol for surface modification.

Main Methods:

• Synthesis of gold nanocubes using facet blocking agents (CTAB/CTAC).
• Ligand exchange with bis(p-sulfonatophenyl) phenyl phosphine (BSPP) as an intermediate capping agent.
• Biofunctionalization of nanocubes with thiol-modified DNA.

Main Results:

• Demonstrated a reliable two-step protocol for DNA biofunctionalization of gold nanocubes.
• Characterized the functionalized nanocubes' electric potential, plasmonic properties, and stability.
• Confirmed successful surface modification for enhanced analytical applications.

Conclusions:

• The developed protocol enables reliable biofunctionalization of gold nanocubes with DNA.
• Functionalized gold nanocubes show potential for advanced diagnostic devices and nanotherapeutics.
• Surface modification is key to enhancing nanoparticle performance in biomedical applications.